Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
---|
02/05/1998 | WO1998004276A1 Use in a composition of an extract of at least one labiate |
02/05/1998 | WO1998004270A1 Use of an oligosaccharide as an immunomodulator in a dermato-cosmetic composition |
02/05/1998 | WO1998004264A1 Methods and compositions to inhibit keratinocyte proliferation |
02/05/1998 | WO1998004263A1 Methods and compositions to inhibit keratinocyte proliferation |
02/05/1998 | WO1997047744A3 T-cell selective interleukin-4 agonists |
02/05/1998 | CA2262564A1 Use of an oligosaccharide as an immunomodulator in a dermato-cosmetic composition |
02/05/1998 | CA2261581A1 Secreted proteins and polynucleotides encoding them |
02/05/1998 | CA2260740A1 A novel human mrna editing enzyme |
02/04/1998 | EP0822255A2 CHO (Chinese Hamster Ovary) glycosylated antibodies and their use in therapy |
02/04/1998 | EP0822190A1 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
02/04/1998 | EP0822186A2 L-tert-leucine-2-pyridylamide |
02/04/1998 | EP0821952A1 Use of isoxazole and crotonic acid amide derivatives for the modulation of apoptosis |
02/04/1998 | EP0821673A1 New form of (e)-3- 6- (2,6-dichlorophenyl)-thio]methyl]-3-(2-phenylethoxy)-2-pyridinyl]-2-propenoic acid |
02/04/1998 | EP0667856B1 Novel vitamin d analogues |
02/04/1998 | CN1172485A Meso-monoiodo-substituted tetramacrocyclic compounds and methods for making and using the same |
02/04/1998 | CN1172483A Substituted heterocyclic compounds, preparation method thereof and pharmaceutical compositions containing same |
02/04/1998 | CN1172434A Use of angiotensin II fragments and analogs thereof in tissue repair |
02/04/1998 | CN1172116A Aprotinin variants having improved properties |
02/04/1998 | CN1171962A Suyuwan pill for curing leucoderma |
02/04/1998 | CN1171953A Feishiting medicine |
02/04/1998 | CN1037235C Use of 6-(substituted amino) purine cytokinin in preparation of antisenlity composition |
02/03/1998 | US5714630 Reacting a serine salt with an activated hydrocarbon derivative in the presence of a phase transfer agent |
02/03/1998 | US5714588 Enhancement of cellular attachment using H3 protein |
02/03/1998 | US5714514 2-Cyano-3-mercaptocrotonamides |
02/03/1998 | US5714504 Alkaline salts of omeprazole; antiulcer agents; magnesium omeprazole or sodium omeprazole for example |
02/03/1998 | US5714155 Ethylenediamine derivative in a cosmetic or dermatological composition, and composition containing in particular a product having an irritant side effect |
01/29/1998 | WO1998003670A1 Induction of t cell tolerance using a soluble molecule that can simultaneously block two costimulatory pathways |
01/29/1998 | WO1998003573A1 Angiogenic inhibitory compounds |
01/29/1998 | WO1998003516A1 Phosphinate based inhibitors of matrix metalloproteases |
01/29/1998 | WO1998003484A1 Substituted pyridines as selective cyclooxygenase-2 inhibitors |
01/29/1998 | WO1998003267A1 A dispensing device and method for forming material |
01/29/1998 | WO1998003180A2 Use of sex steroids function modulators to treat wounds and fibrotic disorders |
01/29/1998 | CA2632790A1 Use of sex steroid function modulators to treat wounds and fibrotic disorders |
01/29/1998 | CA2260752A1 Induction of t cell tolerance using a soluble molecule that can simultaneously block two costimulatory pathways |
01/28/1998 | EP0821007A2 Aprotinin variants with improved properties |
01/28/1998 | EP0820275A1 Cosmetic melanins |
01/28/1998 | EP0820269A1 Method for topical treatment of scar tissue and related tissue reaction to trauma |
01/28/1998 | EP0715613B1 New diphenylhexene |
01/28/1998 | CN1171822A Hydroxyproline-rich proteins and pharmaceutical and cosmetic formulations containing them |
01/28/1998 | CN1171789A 6 -£triazolyl £3 -(trifluoromethyl) phenyl|methyl| -2 -quinolinones and quinolinethiones |
01/28/1998 | CN1171780A Hydroxamic acid-containing inhibitors of matrix metalloproteases |
01/28/1998 | CN1171736A Matrix type patch preparations |
01/28/1998 | CN1171259A Chinese medicine for curing burn and traumatic wound and its production method |
01/27/1998 | US5712397 Amino acid derivatives, processes for preparing them and pharmaceutical compositions containing these compounds |
01/27/1998 | US5712298 Bronchodilator agents, treatment of asthma, antiinflammatory, treatment of skin disorders |
01/27/1998 | US5712294 Antiinflammatory agents |
01/27/1998 | US5712292 N-substituted azaheterocyclic carboxylic acids and esters thereof |
01/27/1998 | US5712291 Methods and compositions for inhibition of angiogenesis |
01/25/1998 | CA2207071A1 Aprotinin variants having improved properties |
01/22/1998 | WO1998002548A2 Infectious papillomavirus pseudoviral particles |
01/22/1998 | WO1998002452A2 Compounds and methods for modulating cell adhesion |
01/22/1998 | WO1998002438A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
01/22/1998 | WO1998002437A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
01/22/1998 | WO1998002436A1 Thiadioxobenzodiazepine inhibitors of farnesyl protein transferase |
01/22/1998 | WO1998002434A1 Fused heterocyclic compounds as protein tyrosine kinase inhibitors |
01/22/1998 | WO1998002177A1 Wound healing accelerators |
01/22/1998 | WO1998002151A2 Chemokine receptor antagonists and methods of use therefor |
01/22/1998 | WO1998002134A1 Methods for altering hair growth and hair pigmentation by apoptosis in the follicular papillae and compositions therefor |
01/22/1998 | WO1998002038A1 Precise efficacy assay methods for active agents including chemotherapeutic agents |
01/22/1998 | DE19627627A1 Solvent extract of intact brood honeycomb |
01/22/1998 | CA2260966A1 Methods for altering hair growth and hair pigmentation by apoptosis in the follicular papillae and compositions therefor |
01/22/1998 | CA2260258A1 Wound healing accelerators |
01/22/1998 | CA2260216A1 Thiadioxobenzodiazepine inhibitors of farnesyl protein transferase |
01/22/1998 | CA2260061A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
01/22/1998 | CA2260058A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
01/22/1998 | CA2259966A1 Compounds and methods for modulating cell adhesion |
01/22/1998 | CA2259927A1 Chemokine receptor antagonists and methods of use therefor |
01/22/1998 | CA2257822A1 Infectious papillomavirus pseudoviral particles |
01/21/1998 | EP0819692A1 Kojic acid derivative as depigmentation agent |
01/21/1998 | EP0819687A1 Benzothiophene compounds, and uses and formulations thereof |
01/21/1998 | EP0819686A1 Benzothiophene compounds, and uses and formulations thereof |
01/21/1998 | EP0819130A1 Ascomycins |
01/21/1998 | EP0819125A1 Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin |
01/21/1998 | EP0819123A1 1,3-dihydro-1-(phenylalkenyl)-2h-imidazol-2-one derivatives having pde iv and cytokine inhibiting activity |
01/21/1998 | EP0819122A1 1,3-dihydro-1-(phenylalkyl)-2h-imidazol-2-one derivatives having pdeiv and cytokine activity |
01/21/1998 | EP0819107A1 9-substituted porphycenes |
01/21/1998 | EP0819008A1 Method of using lectins for prevention and treatment of skin diseases and disorders |
01/21/1998 | EP0701443B1 Terfenadine metabolites and their optically pure isomers for treating allergic disorders |
01/21/1998 | CN1171119A Binding agents for curing inflammatory, autoimmune or allergic diseases |
01/21/1998 | CN1171117A Use of MHC-II binding and/or MHC-II minicking molecules for prevention and/or treatment of inflammatory diseases |
01/21/1998 | CN1171113A Mutants of Rb and p53 genes and uses thereof |
01/21/1998 | CN1170606A Compositions having inhibitive activity against 5 alpha-reductase and antibacterial activity against propionibacterium acnes |
01/21/1998 | CN1170602A Liniment for curing vitiligo and its preparing method |
01/21/1998 | CN1170589A Chinese drug for curing burn and scald |
01/21/1998 | CN1170576A Basin bath medicinal liquid for curing tinea pedis, sweaty feet and smelly feet |
01/20/1998 | US5710294 Treatment of malignant and other diseases characterized by proliferative growth of undifferentiated cells |
01/20/1998 | US5710275 7β-substituted-4-aza-5α-androstan-3-ones as 5α-reductase inhibitors |
01/20/1998 | US5710177 Synergistic combinations of active substance for the cosmetic or dermatological care of the skin, hair & nails |
01/20/1998 | US5710163 Benzo f!quinolinones |
01/20/1998 | US5710142 Vitamin D analogues |
01/20/1998 | US5710141 Panthenol, acne |
01/20/1998 | US5710140 Phenyl heterocycles as COX-2 inhibitors |
01/20/1998 | US5710139 Heterocyclic compounds |
01/20/1998 | US5710136 Inhibition of neovascularization using VEGF-specific oligonucleotides |
01/20/1998 | US5710022 Nuclear mitotic phosphoprotein |
01/20/1998 | US5709996 Self-assembling recombinant papillomavirus capsid proteins |
01/20/1998 | US5709868 Lipoic acid in topical compositions |
01/20/1998 | US5709867 Polyaromatic amide compounds and pharmaceutical/cosmetic compositions comprised thereof |
01/20/1998 | US5709864 Cosmetic or pharmaceutical and particularly dermatological, composition containing an extract of tephrosia, particularly Tephrosia purpurea |
01/20/1998 | US5709853 Method of treatment of atopic disease |